Ethical issues in translational research

Perspectives in Biology and Medicine

Volumn 53, Issue 4, 2010, Pages 517-533

  Petrini, Carlo ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOETHICS; ETHICS; EUROPE; HEALTH CARE POLICY; HUMAN; PUBLIC HEALTH; TRANSLATIONAL RESEARCH; UNITED STATES;

BIOETHICAL ISSUES; EUROPE; HEALTH POLICY; HUMANS; PUBLIC HEALTH; TRANSLATIONAL RESEARCH; UNITED STATES;

EID: 78149235985     PISSN: 00315982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (84)

1. Abdoler, E., H.Taylor, and D.Wendler. 2008.The ethics of phase 0 oncology trials. Clin Canc Res 14(12):3692-3697
2. Adams-Jill, U. 2008. Building the bridge from bench to bedside. Nat Rev Drug Discov 7(6):463-464
3. Albani, S., and B. Prakken. 2009.The advancement of translational medicine: From regional challenges to global solutions. Nat Med 15(9):1006-1009
4. Andorno, E. 2007. First steps in the development of an international bio-law. In New pathways for European bioethics, ed. C. Gastmans, et al., 121-18.Antwerp: Intersentia.
5. Birmingham, K. 2002.What is translational research. Nat Med 8(7):647.
6. Booth, C., and W. J. MacKilliop. 2008. Translating new medical therapies into societal benefit:The role of population-based outcome studies. JAMA 300(18):217-219
7. Butler, D. 2008. Translational research: Crossing the valley of death. Nature 453(7197): 840-842
8. Canadian Institutes of Health Research (CIHR). 2008. About knowledge translation. Ottawa: CIHR. http://www.cihr.ca/e/29418.html.
9. Carter, M.A., and S. S. Night. 2008. From strangers to partners: Emerging forms of research ethics consultation. Am J Bioeth 8(3):29-31.
10. Cho, M. K., et al. 2008. Strangers at the benchside: Research ethics consultation. Am J Bioeth 8(3):4-13.
11. Contopoulos-Ioannidis, D. G., E. Ntzani, and J. P. Ionannidis. 2003.Translation of highly promising basic science research into clinical applications. Am J Med 114(6):477-484
12. Cripe,T. P., et al. 2005. Promoting translational research in academic health centers:Navigating the "roadmap." Acad Med 80(11):1012-1018
13. Cullity, G. 2001. Public goods. In Encyclopedia of ethics, vol.3, ed. L. C. Becker and C. B. Becker, 1413-1416 NewYork: Routledge.
14. Department of Health. 2006.Expert Group on Phase I ClinicalTrials. JointABPI/BIA report. Early Stage ClinicalTrialTask Force. Final report. London:Association of the British Pharmaceutical Industry.
15. Department of Health and Human Services (DHHS). 2009.National Institutes of Health and Office for Human Research Protection. The common rule, title 45 (public welfare), Code of Federal Regulations, part 46 (Protection of human subjects). http://www.hhs.gov/ ohrp/humansubjects/guidance /45cfr46.htm.
16. Derenzo, E., and J.Moss. 2006.Writing clinical research protocols: Ethical considerations. London: Elsevier.
17. Detels,R., and L. Breslow. 2002. Current scope and concerns in public health. In Oxford textbook of public health, ed. R. Detels, et al, 3-20. Oxford: Oxford Univ. Press.
18. Dickert, N., and C. Grady. 1999.What's the price of a research subject? Approaches to payment for research participation. N Engl J Med 341(3):198-203.
19. Dresser,R. 2009. First-in-human trial participants:Not a vulnerable population, but vulnerable nonetheless. J Law Med Ethics 37(1):38-50.
20. EATRIS (European Advanced Translational Research Infrastructure in Medicine). 2008. http://www.eatris.eu.
21. Edwards,R. G., and D. J. Sharpe. 1971. Social values and research in human embryology. Nature 231(5298):87-91.
22. Eliopoulos, H., et al. 2008. Phase 0 trials:An industry perspective. Clin Canc Res 14(12): 3683-3688
23. Emanuel, E. J., D.Wendler, and C. Grady. 2000.What makes clinical research ethical? JAMA 283(20):2701-2711
24. European Commission. 2005. Research ethics committees in Europe: Facing the future together. Conference on research ethics committees in Europe. Final report Brussels, 27-28 January 2005. http://ec.europa.eu/research/conferences/ 2005/recs/index-en. htm.
25. European Parliament and the Council of the European Union. 2001. Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products of human use. Off J Eur Communities, May 1. L121: 34-44.
26. Evans, B. J., and E.M.Meslin. 2006. Encouraging translational research through harmonization of FDA and common rule informed consent requirements for research with banked specimens. J Legal Med 27(2):119-166
27. Evans, H.M. 2004. Should patients be allowed to veto their participation in clinical research? J Med Ethics 30(2):198-203.
28. Evans, J. H. 2008. Keeping society form the benchside. Am J Bioethics 8(3):14-16.
29. Farber Post, L., J. Blustien, and N. Neveloff Dubler. 2007. Handbook for health care ethics committees. Baltimore: Johns Hopkins Univ. Press.
30. Fiscella, K., N. M. Bennett, and P. G. Szilagy. 2008. Nomenclature in translational research. JAMA 299(18):2148-2149
31. Food and Drug Administration (FDA). 2004. Critical Path Report. Innovation or stagnation: Challenge and opportunity on the critical path to new medical products.Washington, DC: FDA.
32. Food and Drug Administration (FDA). 2006. Center for Drug Evaluation and Research (CDER).Guidance for industry, investigators end reviewers: Exploratory IND studies.Washington, DC: FDA.
33. Fox, E. 2002. Ethics consultation in U.S. hospitals:A national study and its implications.Annual Meeting of the American Society for Bioethics and Humanities. October 24, 2002. Baltimore:American Society for Bioethics and Humanities.
34. Golensky, J. D. 1992. Forming a moral community: A methodology for case review. Berkeley: Bioethics Consultation Group.
35. Gordon, B. G., et al. 2002. Paying research subjects. In Institutional review board: Management and function, 2nd ed., ed. E.A. Bankert and R. J.Amdur, 154-159 Sudbury, MA: John and Bartlett.
36. Grady, C., E. Emanuel, and S. Horng. 2003. Consent forms for oncology trials. N Engl J Med 348(15):1496-1497
37. Gutierrez, M., and D. Collyar. 2008. Patient perspectives on phase 0 clinical trials. Clin Canc Res 14(12):3689-3691
38. Hall, J. E. 2001. The promise of translational physiology. Am J Physiol 281(5):G1127-G1128.
39. Hedgecoe, A., et al. 2006. Research ethics committees in Europe: Implementing the directive, respecting diversity. J Med Ethics 32(8):483-486
40. Horig,H., E.Marincola, and F.M.Marincola. 2005.Obstacles and opportunities in translational research. Nat Med 11(7):705-708
41. Joffe, S., and F. G.Miller. 2008. Bench to bedside:Mapping the moral terrain of clinical research. Hastings Cent Rep 38(2):30-42.
42. Jonsen, A. R., R. M.Veatch, and W. LeRoy. 1998. Source book in bioethics: A documentary history.Washington, DC: Georgetown Univ. Press.
43. Kimmelman, J. 2007. Ethics at phase 0:Clarifying the issues. J Law Med Ethics 35(4):727-733
44. Kimmelman, J. 2008. Staunch protections: The ethics of haemophilia gene transfer research. Haemophilia 14(1):5-14.
45. Kimmelman, J. 2009. Gene transfer and the ethics of first in human studies: Lost in translation. Cambridge: Cambridge Univ. Press.
46. Korieth, K. 2005. Zeroing in on microdosing. CenterWatch 12(2):1-17.
47. Lancet. 2009. Phase 0 trials: A platform for drug development? Editorial. Lancet 374(9685):176.
48. Lavis, J.N., et al. 2003.How can research organizations more effectively transfer research knowledge to decision makers? Milbank Q 81(2):221-248
49. Lean, M. E. J., et al. 2008.Translational research: From evidence based medicine to sustainable solutions for public health problems. BMJ 337(7672):705-706
50. Leung,G.M., and S.Gray. 2008.Translational public health: rehearsing the evidence until the task is done. J Pub Health 30(3):217-218
51. London,A. J. 2006.Reasonable risk in clinical research:A critique and a proposal for the integrative approach. Stat Med 25(17):2869-2885
52. Maienschein, J., et al. 2008.The ethos and ethics of translational research. Am J Bioeth 8(3):43-51.
53. Marincola, F. 2003.Translational medicine: A two-way road. J Transl Med 1(1):1.
54. Miller, F. G., and S. Joffe. Limits to research risks. J Med Ethics 35(7):445-449
55. Murgo, A. J., et al. 2008. Designing phase 0 cancer clinical trials. Clin Canc Res 14(12): 3675-3682
56. Nada, A., and J. Somberg. 2007. First-in-man (FIM) clinical trials post TeGenero: A review of the impact of TeGenero trial on design, conduct and ethics of FIM trials. Am J Ther 14(6):594-604.
57. Nuremberg MilitaryTribunals. 1949-1953.The Nuremberg code:Trials of war criminals before the Nuremberg Military Tribunals under Control Council Law n. 10. Nuremberg, October 1946-April 1949.Washington, DC: GPO.
58. O'Donnell,D.O. 1990. First time in man studies:A Contract Research Organization perspective. J Clin Pharmacol 30(3):217-218
59. Operational Research Society. 2009.What operational research is. http://www.orsoc. org.uk/orshop/ (0mr3lk2kfcpddfzeopftsp55)/orcontent.aspx?inc= about.htm.
60. Paycheng, O., and S. Szerman. 2006. Á la rencontre de l'éthique: Guide pratique des textes de référence. Paris: Heures de France.
61. PLoS Medicine. 2008. From theory to practice:Translating research into health outcomes. Editorial. PLoS Med 5(1):e15.
62. Pronovost, P. J., S. M. Berenholtz, and D. M. Needham. 2008.Translating evidence into practice:A model for large scale knowledge translation. BMJ 337(7676):963-965
63. Ramsey, P. 1972. Genetic therapy: A theologian's response. In The new genetics and the future of man, ed.M. Hamilton. Grand Rapids,MI:William B. Eerdemans.
64. Reitsma, A. M. 2009. Ethical issues in innovative surgery. In The Penn Center guide to bioethics, ed.V. Ravitsky, A. Fiester, and A. L. Caplan, 223-233 NewYork: Springer.
65. Rendtorff, J. D. 2002. Basic ethical principles in European bioethics and biolaw: Autonomy, dignity, integrity and vulnerability-towards a foundation of bioethics and bio-law. Med Health Care Philos 5(3):235-244
66. Rhodes, R. 2005. Rethinking research ethics. Am J Bioeth 5(1):7-28.
67. Rothman, D. J. 1991. Strangers at the bedside:A history of how law and bioethics transformed medical decision making. NewYork: Basic Books.
68. Rubin, S., and L. Zoloth-Dorfman. 1994. First-person plural: Community and method in ethics consultation. J Clin Ethics 5(1):49-54.
69. Saunders, P.T. 2008. Experts at the benchside. Am J Bioeth 8(3):20-21.
70. Schaefer, G. O., E. J. Emanuel, and A.Wertheimer. 2009.The obligation to participate in biomedical research. JAMA 302(1):67-72.
71. Smith, R. D. 2003. Global public goods and health. BullWHO 81(7):475.
72. Stamler, J. S.,R. L.Taber, and R.M. Califf. 2003a.Translation of academic discovery into societal benefit: Proposal for a balanced approach. Part 1. Am J Med 115(7):596-599
73. Stamler, J. S.,R. L.Taber, and R.M. Califf. 2003b.Translation of academic discovery into societal benefit: Proposal for a balanced approach. Part 2. Am J Med 115(8):583-588
74. Steinbrook, R. 2002. Protecting research subjects:The crisis of John Hopkins. N Engl J Med 346(9):1904-1906
75. Straus, S. E., J. Tetroe, and I. Graham. 2009. Defining knowledge translation. CMAJ 181(3-4):165-168
76. Sugarman, J. 1999. Ethical considerations in leaping from bench to bedside. Science 285(5436):2071-2072
77. Suntharalingam,G., et al. 2006.Cytokine storm in a phase I trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med 355(10):1018-1028
78. Tishler, C. L., and S. Bartholomae. 2003. Repeat participation among normal healthy research volunteers: Professional guinea pigs in clinical trials? Perspect Biol Med 46(3): 508-520
79. Trevor-Deutsch, B., K. Allen, and V. Ravitsky. 2009. Ethics in knowledge translation. In Knowledge translation in health care: Moving from evidence to practice, ed. S. E. Straus, J. Tetroe, and I. D. Graham, 291-299 Oxford:Wiley-Blackwell.
80. Walley, J., et al. 2007. How to get research into practice: First get practice into research. BullWHO 85(6):424-425
81. Wood, A. J., and J. Darbshire. 2006. Injury to research volunteers:The clinical-research nightmare. N Engl J Med 354(18):1869-1871
82. Woolf, S. H. 2008. The meaning of translational research and why it matters. JAMA 299(2):211-213
83. World Medical Association (WMA). 1964-2008. Declaration of Helsinki: Ethical principles for medical research involving human subjects. Adopted by the 18th WMA General Assembly, Helsinki, Finland, June 1964, amended on October 1975, September 1989, October 1996, October 2000, 2002 (note of clarification on Paragraph 29), 2004 (note of clarification on paragraph 30), and October 2008. http://www.wma.net/en/ 30publications/10policies/b3/index.html.
84. Zherouni, E. 2003.The NIH roadmap. Science 302(5642):63-72.